scispace - formally typeset
Open AccessJournal ArticleDOI

Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.

TLDR
Daily UDCA use modestly influences the relative abundance of microbial species in stool and affects the microbial network composition with suggestive evidence for sex‐specific effects of UDCA on stool microbial community composition as a modifier of colorectal adenoma risk.
Abstract
It has been previously reported that ursodeoxycholic acid (UDCA), a therapeutic bile acid, reduced risk for advanced colorectal adenoma in men but not women. Interactions between the gut microbiome and fecal bile acid composition as a factor in colorectal cancer neoplasia have been postulated but evidence is limited to small cohorts and animal studies. Using banked stool samples collected as part of a phase III randomized clinical trial of UDCA for the prevention of colorectal adenomatous polyps, we compared change in the microbiome composition after a 3-year intervention in a subset of participants randomized to oral UDCA at 8-10 mg/kg of body weight per day (n = 198) or placebo (n = 203). Study participants randomized to UDCA experienced compositional changes in their microbiome that were statistically more similar to other individuals in the UDCA arm than to those in the placebo arm. This reflected a UDCA-associated shift in microbial community composition (P 0.05). These UDCA-associated shifts in microbial community distance metrics from baseline to end-of-study were not associated with risk of any or advanced adenoma (all P > 0.05) in men or women. Separate analyses of microbial networks revealed an overrepresentation of Faecalibacterium prausnitzii in the post-UDCA arm and an inverse relationship between F prausnitzii and Ruminococcus gnavus. In men who received UDCA, the overrepresentation of F prausnitzii and underrepresentation of R gnavus were more prominent in those with no adenoma recurrence at follow-up compared to men with recurrence. This relationship was not observed in women. Daily UDCA use modestly influences the relative abundance of microbial species in stool and affects the microbial network composition with suggestive evidence for sex-specific effects of UDCA on stool microbial community composition as a modifier of colorectal adenoma risk.

read more

Citations
More filters
Journal ArticleDOI

Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.

TL;DR: In this paper , a review of recent studies on the involvement of gut microbiota-derived BAs in intestinal immunity, inflammation, and tumorigenesis along with human omics data to provide prospective insights into future prevention and treatment of IBD and CRC.
Journal ArticleDOI

The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing

TL;DR: Interplay between bile acid metabolism and gut microbiota in intestinal carcinogenesis is discussed and the critical role of bile acids receptors involving in CRC is summarized, and the rationale of multiple interventions for CRC management by regulatingbile acids–microbiota axis is addressed.
Journal ArticleDOI

Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy.

TL;DR: The present review is centred around the anticancer properties of UDCA and synthetic antitumor derivatives designed over the past 20 years, as well as the design of tumour-active derivatives, including UDCA-drug conjugates.
Book ChapterDOI

UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications

TL;DR: Current experimental and clinical data regarding these BAs and its role in the treatment of certain liver diseases are summarized.
Journal ArticleDOI

Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.

TL;DR: In this article, the bile acid-gut microbiota axis is closely connected with IBD pathogenesis and regulation of this axis may be a novel option for treating IBD, which is a chronic, relapsing inflammatory disorder of the gastrointestinal tract, with increasing prevalence, and its pathogenesis remains unclear.
References
More filters
Journal ArticleDOI

Controlling the false discovery rate: a practical and powerful approach to multiple testing

TL;DR: In this paper, a different approach to problems of multiple significance testing is presented, which calls for controlling the expected proportion of falsely rejected hypotheses -the false discovery rate, which is equivalent to the FWER when all hypotheses are true but is smaller otherwise.
Journal ArticleDOI

Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy

TL;DR: The RDP Classifier can rapidly and accurately classify bacterial 16S rRNA sequences into the new higher-order taxonomy proposed in Bergey's Taxonomic Outline of the Prokaryotes, and the majority of the classification errors appear to be due to anomalies in the current taxonomies.
Journal ArticleDOI

DADA2: High-resolution sample inference from Illumina amplicon data

TL;DR: The open-source software package DADA2 for modeling and correcting Illumina-sequenced amplicon errors is presented, revealing a diversity of previously undetected Lactobacillus crispatus variants.
Journal ArticleDOI

Fast unfolding of communities in large networks

TL;DR: This work proposes a heuristic method that is shown to outperform all other known community detection methods in terms of computation time and the quality of the communities detected is very good, as measured by the so-called modularity.
Journal ArticleDOI

MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform

TL;DR: A simplified scoring system is proposed that performs well for reducing CPU time and increasing the accuracy of alignments even for sequences having large insertions or extensions as well as distantly related sequences of similar length.
Related Papers (5)